ITGI Signs Agreement with Vascular Solutions to Commercialize Coronary Covered Stent in US

ITGI announces today the initiation of its activity in the U.S. market. The company has signed a strategic cooperation agreement with U.S.-based Vascular Solutions, Inc.

, an international leader in the interventional cardiology device market. The companies will collaborate to complete a U.S. development program and apply to the Food and Drug Administration for approval under the Humanitarian Device Exemption (HDE) process for ITGI's novel Aneugraft Dx coronary covered stent. Upon approval, Vascular Solutions will distribute ITGI's coronary stent in the U.S. for use in the treatment of perforations and dissections of native coronary arteries, coronary aneurysms, and diseased saphenous vein grafts.